Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals

被引:19
作者
Fritzsching, Benedikt
Korporal, Mirjam
Haas, Juergen
Krammer, Peter H.
Suri-Payer, Elisabeth
Wildemann, Brigitte
机构
[1] Deutsch Krebsforschungszentrum, Tumor Immunol Program D030, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Neurol, Div Mol Neuroimmunol, D-69120 Heidelberg, Germany
关键词
multiple sclerosis; regulatory T cells; auto immunity; apoptosis; CD95;
D O I
10.1016/j.jns.2006.09.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Impaired suppressive function of CD4(+)CD25(high) regulatory T cells (T-reg) has been reported as a novel pathogenetic mechanism in Multiple sclerosis (MS). We addressed if high apoptosis sensitivity of MS-T-reg could explain this functional T-reg defect. T-reg from treatmentnaive MS patients showed high sensitivity towards CD95Ligand-mediated apoptosis and exhibited enhanced cell death to IL-2 and TCR-signal deprivation. Since susceptibility of T-reg to cell death was similar in MS patients and healthy controls, this cannot explain the inhibitory dysfunction of T-reg associated with MS. Furthermore, as cell death is not enhanced, therapeutic expansion of MS-T-reg in vitro should be a reasonable and novel therapeutic option. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 47 条
[1]   Multiple sclerosis:: modulation of apoptosis susceptibility by glatiramer acetate [J].
Aktas, O ;
Ari, N ;
Rieks, M ;
Hoffmann, V ;
Schimrigk, S ;
Przuntek, H ;
Pöhlau, D .
ACTA NEUROLOGICA SCANDINAVICA, 2001, 104 (05) :266-270
[2]   Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis [J].
Beyersdorf, N ;
Gaupp, S ;
Balbach, K ;
Schmidt, J ;
Toyka, KV ;
Lin, CH ;
Hanke, T ;
Hünig, T ;
Kerkau, T ;
Gold, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (03) :445-455
[3]   CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis [J].
Boyer, O ;
Saadoun, D ;
Abriol, J ;
Dodille, M ;
Piette, JC ;
Cacoub, P ;
Klatzmann, D .
BLOOD, 2004, 103 (09) :3428-3430
[4]   Defective T cell Fas function in patients with multiple sclerosis [J].
Comi, C ;
Leone, M ;
Bonissoni, S ;
DeFranco, S ;
Bottarel, F ;
Mezzatesta, C ;
Chiocchetti, A ;
Perla, F ;
Monaco, F ;
Dianzani, U .
NEUROLOGY, 2000, 55 (07) :921-927
[5]   Quantification of regulatory T cells in patients with systemic lupus erythematosus [J].
Crispin, JC ;
Martínez, A ;
Alcocer-Varela, J .
JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) :273-276
[6]   CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis [J].
de Kleer, IM ;
Wedderburn, LR ;
Taams, LS ;
Patel, A ;
Varsani, H ;
Klein, M ;
de Jager, W ;
Pugayung, G ;
Giannoni, F ;
Rijkers, G ;
Albani, S ;
Kuis, W ;
Prakken, B .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6435-6443
[7]   In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation [J].
Earle, KE ;
Tang, Q ;
Zhou, X ;
Liu, W ;
Zhu, S ;
Bonyhadi, ML ;
Bluestone, JA .
CLINICAL IMMUNOLOGY, 2005, 115 (01) :3-9
[8]   Cutting edge:: In contrast to effector T cells, CD4+CD25+ FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death [J].
Fritzsching, B ;
Oberle, N ;
Eberhardt, N ;
Quick, S ;
Haas, J ;
Wildemann, B ;
Krammer, PH ;
Suri-Payer, E .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :32-36
[9]   Decreased levels of CD95 and caspase-8 mRNA in multiple sclerosis patients with gadolinium-enhancing lesions on MRI [J].
Gomes, AC ;
Morris, M ;
Stawiarz, L ;
Jönsson, G ;
Putheti, P ;
Bronge, L ;
Link, H ;
Hillert, J .
NEUROSCIENCE LETTERS, 2003, 352 (02) :101-104
[10]   Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis [J].
Haas, J ;
Hug, A ;
Viehöver, A ;
Fritzsching, B ;
Falk, CS ;
Filser, A ;
Vetter, T ;
Milkova, L ;
Korporal, M ;
Fritz, B ;
Storch-Hagenlocher, B ;
Krammer, PH ;
Suri-Payer, E ;
Wildemann, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (11) :3343-3352